Bibliographic Details
| Title: |
Efficacy and in vitro activity of gepotidacin against bacterial uropathogens, including subsets with molecularly characterized resistance mechanisms and genotypes/epidemiological clones, in females with uncomplicated urinary tract infections: results from two global, pivotal, phase 3 trials (EAGLE-2 and EAGLE-3). |
| Authors: |
Scangarella-Oman NE; GSK, Collegeville, Pennsylvania, USA., Butler DL; GSK, Collegeville, Pennsylvania, USA., Breton J; GSK, Collegeville, Pennsylvania, USA., Brown D; GSK, Collegeville, Pennsylvania, USA., Kasapidis C; GSK, Collegeville, Pennsylvania, USA., Sheets AJ; GSK, Collegeville, Pennsylvania, USA. |
| Source: |
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2025 Oct; Vol. 69 (10), pp. e0163924. Date of Electronic Publication: 2025 Sep 09. |
| Publication Type: |
Journal Article; Clinical Trial, Phase III |
| Journal Info: |
Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
